Cyanide Toxicity and Thiosulfate Protection during Chronic Administration of Sodium Nitroprusside in the Dog

Abstract
Nitroprusside is used acutely for the intraoperative induction of controlled hypotension and chronically for the control of hypertension, decrease of after-load and the treatment of vascular spasm. Dogs were given continuous infusions of various concentrations of sodium nitroprusside (SNP) and monitored for 48 h or until death. Dogs given 0.5 mg/kg per h did not have cyanide [CN] toxicity, achieving and maintaining blood Cn levels of about 2 .mu.g/ml. In animals given SNP, 0.75-1 mg/kg per h, blood cyanide levels increased progressively to above 7 .mu.g/ml and death occurred after 30-38 h. CN toxicity in these animals was evidenced early by progressive metabolic acidosis, increased mixed venous blood O2 tension and decreased O2 consumption. Dogs given SNP, 1 mg/kg per h, plus thiosulfate, 6 mg/kg per h, survived 48 h without evidence of CN toxicity and blood cyanide levels remained low (about 2 .mu.g/ml). Serum thiocyanate levels did not correlate with development of CN toxicity. The results are correlated with the events preceding a human fatality, which occurred after the requirement for SNP increased to between 0.5 and 1 mg/kg per h for 24 h, following prolonged infusion at a much lower dose. Results indicate that the dog is an acceptable model for study of SNP-related CN toxicity; chronic SNP administration should not exceed 0.5 mg/kg per h. Simultaneous thiosulfate administration affords protection against SNP-related CN toxicity; serum thiocyanate levels do not predict or reflect CN toxicity. Development of metabolic acidosis and increased mixed venous blood O2 tension best reflect development of CN toxicity.